GroupPF(N = 199) | GroupPN(N = 201) | P value | 95% CI | Odds ratio | |
---|---|---|---|---|---|
Total adverse events(n)% a | 49(23.62%) | 52(25.88%) | 0.38 | 0.77–1.22 | 0.94 |
Nausea(n)% a | 20 (10.05%) | 18 (8.96%) | 0.35 | 0.78–1.47 | 1.14 |
Vomiting(n)% a | 11 (5.53%) | 11 (5.47%) | 0.49 | 0.65–1.55 | 1.01 |
Pruritus(n)% | 0 | 0 | NS | ||
Aspiration pneumonia(n)% | 0 | 0 | NS | ||
Cough(n)% | 0 | 0 | NS | ||
Polypnea and dyspnoea(n)% a | 1 (0.50%) | 1 (0.50%) | 0.50 | 0.25–4.03 | 1.01 |
Abdominal pain(n)% a | 15 (7.54%) | 16 (7.96%) | 0.44 | 0.67–1.42 | 0.94 |
VAS score(points) b | 0.16 ± 0.75 | 0.13 ± 0.62 | 0.11 | -0.03–0.15 | ––- |
Fever(n)% a | 2 (1.01%) | 6 (2.99%) | 0.08 | 0.15–1.66 | 0.33 |
Medical treatment for adverse events(n)% a | 17 (8.54%) | 18 (8.96%) | 0.44 | 0.8–1.39 | 0.95 |